Yuji Wang

26PUBLICATIONS
43CO-AUTHORS
Biologically active moleculesCancer therapy (excl. chemotherapy and radiation therapy)BiomaterialsTissue engineeringNanomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jul 15, 2026
Comprehensive Evaluation of YJ-2 as a PAD4 Inhibitor in Alleviating Ischemic Brain Injury: From NETs-Induced Neurotoxicity to In Vivo Neuroprotection.

|Jun 18, 2026
Organocatalytic enantioselective synthesis and derivatizations of bridged N,O-acetal bicyclic scaffolds.

|Jun 17, 2026
AI-guided design of self-assembled flavonoid-cisplatin nanoparticles enhances triple-negative breast cancer therapy via three cell-death pathways.

|Mar 28, 2026
Gelatin/Lignin Hydrogel Loaded with Mesenchymal Stem Cell-Derived Exosomes Enriched in Microrna-185 Inhibits Progression of Oral Cancer.

Meitong Liu, Kai Wang, Can Zeng

|Jan 28, 2026
Thermosensitive Hydrogel for Controlled Delivery of PAD4 Inhibitor YJ-2 in Diabetic Wound Healing.

Kai Wang, Ayijiang Taledaohan, Liujia Chan

|Nov 27, 2025
Reversing the Warburg Effect: YW3-56 Induces Leukemia Differentiation via AKT-Mediated Glucose Metabolic Reprogramming.

Di Zhu, Dan Gao, Yu Lu

Pageof 5

Frequent Collaborators

5 joint publications

Wei Wang

4 joint publications

Yijiang Jia

3 joint publications

Yu Lu

3 joint publications

Di Zhu